The latest research shows that berberine significantly decreases the expression of GFAP in the Alzheimer’s disease mice hippocampus, indicating berberine inhibits the overexpression of astrocytes in Alzheimer’s disease mice. This evidence concerns the gene GFAP and Alzheimer disease.